Author

Emma E. Russo

University of TorontoORCID 0009-0006-1102-8553Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aled Blundell· 1 shared Ali SalahpouriD· 1 shared Ameneh RezayofiD· 1 shared Amy J. RamseyiD· 1 shared Conner W. WallaceiD· 1 shared Dawn E. Watkins‐ChowiD· 1 shared Erin Q. Williams· 1 shared Jason L. Locke· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Aled Blundell

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Characterization of a novel mouse model of Dopamine Transporter Deficiency Syndrome and pharmacological therapeutic strategies

Emma E. Russo, Ameneh Rezayof, Conner W. Wallace, Erin Q. Williams, Pieter Beerepoot, Marija Milenkovic, Maria Novalen, Aled Blundell, Tatiana V. Lipina, Jason L. Locke, Raveen Christian, Peter S.B. Finnie, Landon J. Edgar, Rachel Fynvola Tyndale, Dawn E. Watkins‐Chow, , Ali Salahpour

This study creates a mouse model of DTDS with the A313V DAT variant and identifies two potential treatments, [a]MPT and AMPH, that reduce hyperactivity.

bioRxiv · Mar 21, 2025 · PreprintPharmacology & Toxicology